Development and Characterization of SMEDDS Based Thermally Triggered In Situ Gelling Intramuscular Implant for Sustained Release of Rifampicin

Publisher： Bentham Science Publishers

E-ISSN： 1877-9131|5|1|38-47

ISSN： 1877-9123

Source： Recent Patents on Nanomedicine, Vol.5, Iss.1, 2015-01, pp. : 38-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan

By El Maghraby Gamal M.   Elzayat Ehab M.   Alanazi Fars K.  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 8, 2012-08 ,pp. : 971-978

Informa Healthcare

Access to resources Recommend Favorite

Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers

By Al-Kassas Raida S.   El-Khatib Mona M.  

Drug Delivery, Vol. 16, Iss. 3, 2009-04 ,pp. : 145-152

Informa Healthcare

Access to resources Recommend Favorite

The influence of the degree of esterification on the release characteristics of in situ gelling pectin formulations for oral sustained delivery of paracetamol

By Miyazaki Shozo  

Pharmaceutical Development and Technology, Vol. 18, Iss. 5, 2013-10 ,pp. : 1259-1264

Informa Healthcare

Access to resources Recommend Favorite

Design, Development and Characterization of Liquid Oral Sustained Release in situ Gel Formulation of Glimepiride

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 3, Iss. 2, 2016-08 ,pp. : 117-126

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Development and Characterization of Liquid Oral Sustained Release in situ Gel Formulation of Glimepiride

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 3, Iss. 2, 2016-08 ,pp. : 117-126

Bentham Science Publishers

Access to resources Recommend Favorite